1. Home
  2. UBFO vs CGEN Comparison

UBFO vs CGEN Comparison

Compare UBFO & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Security Bancshares

UBFO

United Security Bancshares

HOLD

Current Price

$10.46

Market Cap

182.7M

Sector

Finance

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.90

Market Cap

188.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBFO
CGEN
Founded
1987
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.7M
188.2M
IPO Year
2001
2001

Fundamental Metrics

Financial Performance
Metric
UBFO
CGEN
Price
$10.46
$2.90
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
48.2K
328.1K
Earning Date
04-17-2026
05-18-2026
Dividend Yield
4.57%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$2,954,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
$15.01
N/A
Revenue Growth
1.23
N/A
52 Week Low
$7.80
$1.23
52 Week High
$11.52
$2.94

Technical Indicators

Market Signals
Indicator
UBFO
CGEN
Relative Strength Index (RSI) 55.01 79.89
Support Level $9.31 $1.45
Resistance Level $10.53 N/A
Average True Range (ATR) 0.20 0.16
MACD 0.04 0.07
Stochastic Oscillator 75.00 95.83

Price Performance

Historical Comparison
UBFO
CGEN

About UBFO United Security Bancshares

United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: